An open-label, randomised, multicentre, phase IIIb/IV, parallel group study to compare the efficacy and safety of rosuvastatin and atorvastatin in subjects with type IIa and IIb hypercholesterolaemia (DISCOVERY)

Trial Profile

An open-label, randomised, multicentre, phase IIIb/IV, parallel group study to compare the efficacy and safety of rosuvastatin and atorvastatin in subjects with type IIa and IIb hypercholesterolaemia (DISCOVERY)

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2009

At a glance

  • Drugs Rosuvastatin (Primary) ; Atorvastatin
  • Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II
  • Focus Therapeutic Use
  • Acronyms DISCOVERY; DISCOVERY Asia
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Feb 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
    • 23 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top